AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2021
Nov 30, 2021
33298_dirs_2021-11-30_474abb95-dbc0-4131-bc27-76441e9a5410.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-11-30
Reporting Person: BHATIA NAVEEN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-30 | Common Stock, par value $0.01 | P | 50000 | $3.876 | Acquired | 146349 | Direct |
Footnotes
F1: The price reported is a weighted average price.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17